Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Immuneering Corporation per 2025 Jun 30 adalah -64.07 MM.
- Nilai net income untuk Immuneering Corporation per 2025 Jun 30 adalah -62.13 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -64.07 | -62.13 | |
2025-03-31 | -64.23 | -61.77 | |
2024-12-31 | -64.07 | -61.04 | |
2024-09-30 | -61.82 | -58.07 | |
2024-06-30 | -60.47 | -56.07 | |
2024-03-31 | -59.06 | -54.18 | |
2023-12-31 | -58.41 | -53.47 | |
2023-09-30 | 0.00 | -56.10 | -51.63 |
2023-06-30 | 0.04 | -55.36 | -51.88 |
2023-03-31 | 0.13 | -53.50 | -51.22 |
2022-12-31 | 0.32 | -51.74 | -50.51 |
2022-09-30 | 0.51 | -48.88 | -48.05 |
2022-06-30 | 0.95 | -44.23 | -43.74 |
2022-03-31 | 1.52 | -40.58 | -40.20 |
2021-12-31 | 2.08 | -33.89 | -33.54 |
2021-09-30 | 2.56 | -28.61 | -28.59 |
2021-06-30 | 2.76 | -24.46 | -24.45 |
2021-03-31 | 2.58 | -20.08 | -20.07 |
2020-12-31 | 2.31 | -17.08 | -17.04 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk Immuneering Corporation pada 2025 Jun 30 adalah -1.88.
- laba per saham yang terdilusi untuk Immuneering Corporation pada 2025 Jun 30 adalah -1.88.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | -1.88 | -1.88 |
2025-03-31 | -1.96 | -1.96 |
2024-12-31 | -2.04 | |
2024-09-30 | -1.97 | -1.97 |
2024-06-30 | -1.91 | -1.91 |
2024-03-31 | -1.86 | -1.86 |
2023-12-31 | -1.88 | |
2023-09-30 | -1.86 | -1.86 |
2023-06-30 | -1.92 | -1.92 |
2023-03-31 | -1.94 | -1.94 |
2022-12-31 | -1.91 | |
2022-09-30 | -1.83 | -1.83 |
2022-06-30 | -1.80 | -1.80 |
2022-03-31 | -2.12 | -2.12 |
2021-12-31 | -2.46 | |
2021-09-30 | -3.44 | -3.43 |
2021-06-30 | -4.94 | -4.94 |
2021-03-31 | -4.05 | -4.05 |
2020-12-31 | -3.44 | -3.44 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Immuneering Corporation per 2025 Jun 30 adalah -51.51 MM.
- Nilai cash from investing activities untuk Immuneering Corporation per 2025 Jun 30 adalah 0.06 MM.
- Nilai kas dari aktivitas pendanaan untuk Immuneering Corporation per 2025 Jun 30 adalah 18.07 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -51.51 | 0.06 | 18.07 |
2025-03-31 | -53.59 | 5.03 | 18.13 |
2024-12-31 | -55.00 | 26.43 | 5.30 |
2024-09-30 | -52.26 | 24.08 | 5.35 |
2024-06-30 | -50.82 | 5.52 | 1.01 |
2024-03-31 | -50.04 | 9.72 | 29.18 |
2023-12-31 | -48.97 | 7.30 | 28.44 |
2023-09-30 | -48.94 | 12.32 | 28.25 |
2023-06-30 | -47.54 | 35.41 | 28.21 |
2023-03-31 | -46.24 | 48.40 | 0.07 |
2022-12-31 | -44.10 | 41.83 | 0.02 |
2022-09-30 | -41.59 | 10.87 | 0.21 |
2022-06-30 | -40.00 | -41.02 | 118.72 |
2022-03-31 | -36.99 | -63.19 | 144.46 |
2021-12-31 | -30.85 | -75.62 | 144.26 |
2021-09-30 | -27.07 | -52.85 | 181.24 |
2021-06-30 | -21.52 | -0.08 | 62.75 |
2021-03-31 | -18.45 | -0.07 | 36.98 |
2020-12-31 | -14.62 | -0.05 | 37.98 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Immuneering Corporation pada 2025 Jun 30 adalah -1.95.
- p/libro untuk Immuneering Corporation pada 2025 Jun 30 adalah 2.88.
- p/tbv untuk Immuneering Corporation pada 2025 Jun 30 adalah 3.46.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -1.95 | 2.88 | 3.46 |
2025-03-31 | 1.42 | 1.71 | |
2024-12-31 | 1.21 | 1.38 | |
2024-09-30 | -1.41 | 1.19 | 1.33 |
2024-06-30 | -0.78 | 0.54 | 0.59 |
2024-03-31 | 0.79 | 0.85 | |
2023-12-31 | -4.18 | 2.07 | 2.23 |
2023-09-30 | -4.35 | 1.96 | 2.09 |
2023-06-30 | -5.47 | 2.87 | 3.09 |
2023-03-31 | -5.03 | 2.32 | |
2022-12-31 | 1.05 | 1.12 | |
2022-09-30 | 2.79 | 2.94 | |
2022-06-30 | -3.54 | 0.99 | 1.04 |
2022-03-31 | -5.07 | 1.09 | 1.14 |
2021-12-31 | -14.71 | 2.66 | 2.66 |
2021-09-30 | -28.15 | 14.43 | 14.43 |
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Immuneering Corporation pada 2025 Jun 30 adalah -0.73.
- EBIT (3 tahun) / EV untuk Immuneering Corporation pada 2025 Jun 30 adalah -0.67.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.73 | -0.67 |
2025-03-31 | -2.69 | -2.44 |
2024-12-31 | -2.35 | -2.19 |
2024-09-30 | -2.93 | -2.72 |
2024-06-30 | 2.27 | 2.04 |
2024-03-31 | -4.55 | -3.91 |
2023-12-31 | -0.35 | -0.29 |
2023-09-30 | -0.43 | -0.33 |
2023-06-30 | -0.25 | -0.20 |
2023-03-31 | -0.28 | -0.20 |
2022-12-31 | -0.94 | -0.50 |
2022-09-30 | -0.15 | -0.09 |
2022-06-30 | -0.60 | -0.36 |
2022-03-31 | -0.36 | -0.22 |
2021-12-31 | -0.07 | -0.04 |
2021-09-30 | -0.03 | -0.01 |
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 |
Efektivitas Manajemen
- roa untuk Immuneering Corporation pada 2025 Jun 30 adalah -0.80.
- roe untuk Immuneering Corporation pada 2025 Jun 30 adalah -0.93.
- roic untuk Immuneering Corporation pada 2025 Jun 30 adalah -1.35.
- croic untuk Immuneering Corporation pada 2025 Jun 30 adalah -0.66.
- ocroic untuk Immuneering Corporation pada 2025 Jun 30 adalah -1.17.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.80 | -0.93 | -1.35 | -0.66 | -1.17 |
2025-03-31 | -0.69 | -0.78 | -1.34 | -0.51 | -1.21 |
2024-12-31 | -0.57 | -0.64 | -0.94 | -0.37 | -0.84 |
2024-09-30 | -0.49 | -0.54 | -0.79 | -0.63 | -0.72 |
2024-06-30 | -0.50 | -0.55 | -0.65 | -0.13 | -0.60 |
2024-03-31 | -0.44 | -0.49 | -0.56 | -0.14 | -0.52 |
2023-12-31 | -0.39 | -0.42 | -0.48 | -0.08 | -0.45 |
2023-09-30 | -0.37 | -0.39 | -0.43 | 0.13 | -0.40 |
2023-06-30 | -0.36 | -0.38 | -0.43 | 0.13 | -0.40 |
2023-03-31 | -0.33 | -0.35 | -0.50 | 0.02 | -0.45 |
2022-12-31 | -0.29 | -0.30 | -0.38 | -0.24 | -0.33 |
2022-09-30 | -0.27 | -0.28 | -0.38 | -0.24 | -0.33 |
2022-06-30 | -0.76 | -0.84 | -0.32 | 0.27 | -0.29 |
2022-03-31 | -1.02 | -1.13 | -0.27 | 0.30 | -0.25 |
2021-12-31 | -0.74 | -0.80 | -0.21 | 0.23 | -0.17 |
2021-09-30 | -2.42 | -0.18 | 0.64 | -0.45 | |
2021-06-30 | -1.73 | -2.42 | -0.51 | 0.85 | -0.45 |
2021-03-31 | -1.42 | -1.99 | -0.67 | 0.61 | -0.61 |
2020-12-31 | -1.21 | -1.69 | -0.47 | 0.64 | -0.40 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | 1.00 | -119,066.55 | -129,800.14 |
2024-03-31 | 1.00 | -117,520.05 | -128,379.97 |
2023-12-31 | 1.00 | -113,480.64 | -123,287.71 |
2023-09-30 | 0.50 | -1,335.98 | -1,425.46 |
2023-06-30 | 0.50 | -1,335.98 | -1,425.46 |
2023-03-31 | 0.50 | -384.39 | -401.48 |
2022-12-31 | 0.28 | -94.95 | -96.58 |
2022-09-30 | 0.41 | -94.95 | -96.58 |
2022-06-30 | 0.45 | -46.05 | -46.57 |
2022-03-31 | 0.45 | -26.53 | -26.77 |
2021-12-31 | 0.44 | -16.12 | -16.29 |
2021-09-30 | 0.45 | -11.19 | -11.19 |
2021-06-30 | 0.45 | -8.87 | -8.88 |
2021-03-31 | 0.44 | -7.79 | -7.79 |
2020-12-31 | 0.45 | -7.37 | -7.39 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1790340 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |